Posted in | News | Microbotics

Pilus Energy Selected Among 50 Top Innovators to Present at Venture Summit West 2014

Tauriga Sciences, Inc. ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space, today announced that its Pilus Energy LLC ("Pilus Energy") subsidiary has been selected as one of 50 Top Innovators to present at Venture Summit West 2014.

This showcase will take place on February 12, 2014 at the Computer History Museum in Mountain View, California (Silicon Valley). Presenting on behalf of Pilus Energy LLC will be Dr. Stella M. Sung, Chief Operating Officer ("COO") of its parent company Tauriga Sciences, Inc. The extensive list of attending institutional investors and VC firms will provide Pilus Energy with a valuable opportunity to showcase its cutting edge solution to the joined global issues of water and energy.

The Second annual Venture Summit West, presented by youngStartup Ventures, is the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of early stage and emerging growth companies, university researchers, incubators and premier service providers. For more information please visit the official conference website at (http://www.youngstartup.com/west2014/overview.php).

Tauriga's COO Dr. Stella M. Sung commented, "We are delighted to present the Pilus Energy synthetic biology-based 'waste-to-value' approach at the Venture Summit West. This is the ideal forum to showcase our innovative technology to leading venture capitalists and institutional investor focused on potentially disruptive emerging technologies."

Partial List of Institutional Investors and VCs Confirmed to Attend:

Dan Ahn, Managing Director, Voyager Capital | Julien Creuzé, Senior Associate, Aster Capital | Duncan Dashiff, Co-Founder & Managing Director, Epiphany Health Ventures | Stephen DeBerry, Chief Investment Officer, Bronze Investments | Andy Donner, Investment Director, Unilever Ventures | Ted Driscoll, Partner, Claremont Creek Ventures | Michael Dybbs, Principal, New Leaf Venture Partners | Andrew Farquharson, Managing Director, InCube Ventures | Mark Gorenberg, Managing Director, Hummer Winblad Venture Partners | Tim Guleri, Managing Director, Sierra Ventures | Mike Hammons, Partner, Sail Capital Partners | Nathaniel Henshaw, Managing Director, CEI Ventures | Caribou Honig, Founding Partner, QED Investors | David Hornik, General Partner, August Capital | Nadeem Kassam, Director, Zynik Capital | John Kim, Managing Partner, Highbar Partners | Yoav Andrew Leitersdorf, Managing Partner, YL Ventures | Noah Lichtenstein, Partner, Cowboy Ventures | John Loiacono, Venture Partner & Market Strategist | Jim Long, Partner, Gabriel Venture Partners | Jeb Miller, General Partner, Jafco Ventures | Peter Moran, General Partner, DCM | Umesh Padval, Partner, Bessemer Venture Partners | Renata Quintini, Partner, Felicis Ventures | Bill Reichert, Managing Director, Garage Technology Ventures | Lisa Rhoads, Managing Director, Easton Capital Investment Group | Rosemary Ripley, Managing Director, NGEN Partners | Miriam Rivera, Co-Founder & Managing Partner, Ulu Ventures | Mary Rozenman, Vice President, Longitude Capital | Ned Scheetz, Managing Director & Founder, Aphelion Capital | Rupam Shrivastava, Director, ePlanet Capital | David Siemer, Managing Partner, Siemer Ventures | Michael Staton, Partner, Learn Capital | Mark Silverman, Partner, Catamount Ventures | John Steuart, Managing Director, Prolog Ventures | Bruce Taragin, Managing Director, Blumberg Capital | Sharon Wienbar, Partner, Scale Venture Partners and many more.

On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. Accordingly, Pilus Energy now operates a wholly-owned subsidiary of Tauriga Sciences, Inc.

About Tauriga Sciences, Inc.:

Tauriga Sciences, Inc. (TAUG) is a diversified company focused on generating profitable revenues through license agreements and the development of a proprietary technology platform in the nano-robotics space. The mission of the Company is to acquire and build a diversified portfolio of cutting edge technology assets that is capital efficient and of significant value to the shareholders. The Company's business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses. Management is firmly committed to building lasting shareholder value in the short, intermediate, and long terms. On January 28, 2014 the Company completed its acquisition of Cincinnati, Ohio based Pilus Energy LLC ("Pilus Energy"), a developer of alternative cleantech energy platforms using proprietary microbial solutions that creates electricity while consuming polluting molecules from wastewater. The Company's corporate website can be found at (www.tauriga.com).

About Pilus Energy LLC

A developer of alternative cleantech energy solutions, Pilus Energy is developing microbial solutions that clean polluting molecules from wastewater. In the process, the technology generates electricity and produces economically important gases and chemicals. Pilus Energy licenses a low-cost, scalable electrogenic bioreactor platform and wastewater-to-value BactoBots. Pilus Energy will also derive additional revenues from carbon and renewable energy credits (REC). Pilus Energy is a wholly-owned subsidiary of Danbury, CT based Tauriga Sciences, Inc. (OTCQB:TAUG). For more information, please visit Pilus Energy's web site, (www.pilusenergy.com).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.